Sigma Laboratories Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 17.00 Cr
as on 16-11-2024
- Company Age 37 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 33.78 Cr
as on 16-11-2024
- Satisfied Charges ₹ 110.25 Cr
as on 16-11-2024
- Revenue 16.77%
(FY 2023)
- Profit 111.69%
(FY 2023)
- Ebitda 1743.66%
(FY 2023)
- Net Worth 24.84%
(FY 2023)
- Total Assets 0.98%
(FY 2023)
About Sigma Laboratories
The Corporate was formerly known as Sigma Laboratories Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 17.00 Cr.
The company currently has active open charges totaling ₹33.78 Cr. The company has closed loans amounting to ₹110.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sigma Laboratories Private Limited India are Priya Coulagi as CFO and Tanvi Shah as Company Secretary. Kavita Coulagi and Priya Coulagi serve as directors at the Company.
- CIN/LLPIN
U85195MH1987PTC043007
- Company No.
043007
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 1987
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sigma Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priya Coulagi  | CFO | 03-Apr-2015 | Current |
| Tanvi Shah | Company Secretary | 01-Apr-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priya Coulagi | Whole-Time Director and Cfo | 03-Apr-2015 | Current |
| Kavita Coulagi | Whole-Time Director | 14-Aug-2015 | Current |
Financial Performance and Corporate Structure Insights of Sigma Laboratories.
Sigma Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.77% increase. The company also saw a substantial improvement in profitability, with a 111.69% increase in profit. The company's net worth Soared by an impressive increase of 24.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sigma Laboratories?
In 2023, Sigma Laboratories had a promoter holding of 92.00% and a public holding of 8.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Nov 2012 | ₹33.78 Cr | Open |
Hdfc Bank Limited Creation Date: 28 Oct 2015 | ₹1.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 28 Oct 2015 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Sigma Laboratories?
Sigma Laboratories has a workforce of 18 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sigma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sigma Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
